HLA-DR in cytotoxic T lymphocytes predicts breast cancer patients' response to neoadjuvant chemotherapy

This work was supported by iNOVA4Health - UID/Multi/04462/2013 - LISBOA-01-0145-FEDER-007344, Fundacao para a Ciencia e Tecnologia - PD/BD/114023/2015 and PTDC/BBB-BMD/4497/2014. Liga Portuguesa Contra o Cancro.

Detalhes bibliográficos
Autor principal:	Saraiva, Diana P. (author)
Outros Autores:	Jacinto, António (author), Borralho, Paula (author), Braga, Sofia (author), Cabral, M. Guadalupe (author)
Formato:	article
Idioma:	eng
Publicado em:	2018
Assuntos:	Breast cancer Cytotoxic T lymphocytes HLA-DR Neoadjuvant chemotherapy Prediction Immunology and Allergy Immunology SDG 3 - Good Health and Well-being
Texto completo:	https://doi.org/10.3389/fimmu.2018.02605
País:	Portugal
Oai:	oai:run.unl.pt:10362/54695

Descrição
Resumo:	This work was supported by iNOVA4Health - UID/Multi/04462/2013 - LISBOA-01-0145-FEDER-007344, Fundacao para a Ciencia e Tecnologia - PD/BD/114023/2015 and PTDC/BBB-BMD/4497/2014. Liga Portuguesa Contra o Cancro.